Literature DB >> 18043536

Cross-bridged macrocyclic chelators for stable complexation of copper radionuclides for PET imaging.

C J Anderson1, T J Wadas, E H Wong, G R Weisman.   

Abstract

Copper-64 (t(1/2)=12.7 h; beta+: 17.4%; E(beta+max)=656 keV; beta-: 39%; E(beta-max)=573 keV) has emerged as an important non-standard positron-emitting radionuclide for positron emission tomography imaging of diseased tissues. A significant challenge of working with copper radionuclides is that they must be delivered to the living system as a stable complex that is attached to a biological targeting molecule for effective imaging and therapy. Significant research has been devoted to the development of ligands that can stably chelate (64)Cu, in particular, the cross-bridged (CB) macrocyclic chelators. This review describes the coordination chemistry and biological behavior of (64)Cu-labeled CB complexes.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18043536      PMCID: PMC4286870     

Source DB:  PubMed          Journal:  Q J Nucl Med Mol Imaging        ISSN: 1824-4785            Impact factor:   2.346


  34 in total

1.  Production and applications of copper-64 radiopharmaceuticals.

Authors:  Xiankai Sun; Carolyn J Anderson
Journal:  Methods Enzymol       Date:  2004       Impact factor: 1.600

2.  Chelating agents for the binding of metal ions to antibodies.

Authors:  C F Meares
Journal:  Int J Rad Appl Instrum B       Date:  1986

3.  64Cu-TETA-octreotide as a PET imaging agent for patients with neuroendocrine tumors.

Authors:  C J Anderson; F Dehdashti; P D Cutler; S W Schwarz; R Laforest; L A Bass; J S Lewis; D W McCarthy
Journal:  J Nucl Med       Date:  2001-02       Impact factor: 10.057

4.  Preparation and biological evaluation of copper-64-labeled tyr3-octreotate using a cross-bridged macrocyclic chelator.

Authors:  Jennifer E Sprague; Yijie Peng; Xiankai Sun; Gary R Weisman; Edward H Wong; Samuel Achilefu; Carolyn J Anderson
Journal:  Clin Cancer Res       Date:  2004-12-15       Impact factor: 12.531

5.  Optimization of labeling and metabolite analysis of copper-64-labeled azamacrocyclic chelators by radio-LC-MS.

Authors:  C Andrew Boswell; Paul McQuade; Gary R Weisman; Edward H Wong; Carolyn J Anderson
Journal:  Nucl Med Biol       Date:  2005-01       Impact factor: 2.408

6.  MicroPET imaging of breast cancer alphav-integrin expression with 64Cu-labeled dimeric RGD peptides.

Authors:  Xiaoyuan Chen; Shuang Liu; Yingping Hou; Michel Tohme; Ryan Park; James R Bading; Peter S Conti
Journal:  Mol Imaging Biol       Date:  2004 Sep-Oct       Impact factor: 3.488

7.  Dosimetry of copper-64-labeled monoclonal antibody 1A3 as determined by PET imaging of the torso.

Authors:  P D Cutler; S W Schwarz; C J Anderson; J M Connett; M J Welch; G W Philpott; B A Siegel
Journal:  J Nucl Med       Date:  1995-12       Impact factor: 10.057

8.  Copper chelates as probes of biological systems: stable copper complexes with a macrocyclic bifunctional chelating agent.

Authors:  M K Moi; C F Meares; M J McCall; W C Cole; S J DeNardo
Journal:  Anal Biochem       Date:  1985-07       Impact factor: 3.365

9.  Subcellular localization of radiolabeled somatostatin analogues: implications for targeted radiotherapy of cancer.

Authors:  Mu Wang; Amy L Caruano; Michael R Lewis; Laura A Meyer; Robert P VanderWaal; Carolyn J Anderson
Journal:  Cancer Res       Date:  2003-10-15       Impact factor: 12.701

Review 10.  Copper biochemistry and molecular biology.

Authors:  M C Linder; M Hazegh-Azam
Journal:  Am J Clin Nutr       Date:  1996-05       Impact factor: 7.045

View more
  27 in total

1.  Comparative evaluation of three 64Cu-labeled E. coli heat-stable enterotoxin analogues for PET imaging of colorectal cancer.

Authors:  Dijie Liu; Douglas Overbey; Lisa D Watkinson; Charles J Smith; Said Daibes-Figueroa; Timothy J Hoffman; Leonard R Forte; Wynn A Volkert; Michael F Giblin
Journal:  Bioconjug Chem       Date:  2010-07-21       Impact factor: 4.774

Review 2.  Coordinating radiometals of copper, gallium, indium, yttrium, and zirconium for PET and SPECT imaging of disease.

Authors:  Thaddeus J Wadas; Edward H Wong; Gary R Weisman; Carolyn J Anderson
Journal:  Chem Rev       Date:  2010-05-12       Impact factor: 60.622

Review 3.  Immuno-positron emission tomography in cancer models.

Authors:  Smitha Reddy; Matthew K Robinson
Journal:  Semin Nucl Med       Date:  2010-05       Impact factor: 4.446

4.  Metallic radionuclides in the development of diagnostic and therapeutic radiopharmaceuticals.

Authors:  Sibaprasad Bhattacharyya; Manish Dixit
Journal:  Dalton Trans       Date:  2011-05-03       Impact factor: 4.390

5.  Synthesis and radiolabeling of chelator-RNA aptamer bioconjugates with copper-64 for targeted molecular imaging.

Authors:  William M Rockey; Ling Huang; Kyle C Kloepping; Nicholas J Baumhover; Paloma H Giangrande; Michael K Schultz
Journal:  Bioorg Med Chem       Date:  2011-05-14       Impact factor: 3.641

6.  Bimodal thrombus imaging: simultaneous PET/MR imaging with a fibrin-targeted dual PET/MR probe--feasibility study in rat model.

Authors:  Ritika Uppal; Ciprian Catana; Ilknur Ay; Thomas Benner; A Gregory Sorensen; Peter Caravan
Journal:  Radiology       Date:  2010-12-21       Impact factor: 11.105

7.  64Cu-AMD3100--a novel imaging agent for targeting chemokine receptor CXCR4.

Authors:  Orit Jacobson; Ido D Weiss; Lawrence Szajek; Joshua M Farber; Dale O Kiesewetter
Journal:  Bioorg Med Chem       Date:  2009-01-15       Impact factor: 3.641

8.  Aspartate-Based CXCR4 Chemokine Receptor Binding of Cross-Bridged Tetraazamacrocyclic Copper(II) and Zinc(II) Complexes.

Authors:  Randall D Maples; Amy N Cain; Benjamin P Burke; Jon D Silversides; Ryan E Mewis; Thomas D'huys; Dominique Schols; Douglas P Linder; Stephen J Archibald; Timothy J Hubin
Journal:  Chemistry       Date:  2016-07-26       Impact factor: 5.236

9.  Copper-64 radiopharmaceuticals for PET imaging of cancer: advances in preclinical and clinical research.

Authors:  Carolyn J Anderson; Riccardo Ferdani
Journal:  Cancer Biother Radiopharm       Date:  2009-08       Impact factor: 3.099

10.  "Click"-cyclized (68)Ga-labeled peptides for molecular imaging and therapy: synthesis and preliminary in vitro and in vivo evaluation in a melanoma model system.

Authors:  Molly E Martin; M Sue O'Dorisio; Whitney M Leverich; Kyle C Kloepping; Susan A Walsh; Michael K Schultz
Journal:  Recent Results Cancer Res       Date:  2013
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.